We are talking about a process that's fairly new for the provinces. The pan-Canadian Pharmaceutical Alliance, or pCPA, is a system for negotiating drug prices that has been around for four or five years. This is a rather new concept in Canada and shows that progress is being made on the issue.
As Mr. Swedlove mentioned, we believe that progress can continue with the inclusion of private insurers, as is done for generic drugs and subsequent entry biologics. This concept is new to the system, and we are maintaining good dialogue with the provinces and the federal government.